Source: BioPharma-Reporter

SFL: Veristat expands in Europe with SLF acquisition

Clinical Research Organization Veristat has acquired SLF (Solutions for Life Sciences): adding capabilities to support biotech, pharmaceutical and medtech companies.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Shayesteh Fuerst-Ladani's photo - Founder & CEO of SFL

Founder & CEO

Shayesteh Fuerst-Ladani

CEO Approval Rating

90/100

Read more